VDA-1102 Demonstrates Favorable Activity in Mycosis Fungoides
VDA-1102 led to an objective response rate of 56% in patients with mycosis fungoides, according to findings from an interim analysis of a phase 2a study.
Source: onclive.com
Stay updated with breaking news from Vda 1102 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VDA-1102 led to an objective response rate of 56% in patients with mycosis fungoides, according to findings from an interim analysis of a phase 2a study.